ArticleClinical & translational immunology2023

A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases.

Callum Ah Docherty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.